84827-06-5 Usage
Classification
Central nervous system stimulant
Effects
Similar to amphetamine
Previous Medical Use
Treatment for attention-deficit/hyperactivity disorder (ADHD) and narcolepsy
Current Status
Discontinued medical use, controlled substance in many countries
Mechanism of Action
Increases dopamine and norepinephrine levels in the brain
Potential Risks
Abuse, addiction, misuse, dependence
Regulatory Status
Controlled substance
Monitoring Requirements
Strict monitoring and control of usage
Check Digit Verification of cas no
The CAS Registry Mumber 84827-06-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,8,2 and 7 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 84827-06:
(7*8)+(6*4)+(5*8)+(4*2)+(3*7)+(2*0)+(1*6)=155
155 % 10 = 5
So 84827-06-5 is a valid CAS Registry Number.
84827-06-5Relevant academic research and scientific papers
PYRIDINE DERIVATIVES AS SODIUM CHANNEL BLOCKERS
-
Page/Page column 30-31, (2010/11/30)
Compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein; each of R1 to R4 is independently selected from hydrogen and C1-4 alkyl, and each of rings A and B independently is optionally further substi
QUINAZOLINE DERIVATIVES
-
Page/Page column 199, (2008/06/13)
A quinazoline derivative of the formula (I) wherein: R1, R2, R3, R3a, R4, R5, R5a R6, R7, a, m and p are as defined in the description. Also claimed are pharmaceutical compositions containing the quinazoline derivative, the use of the quinazoline derivatives as medicaments and processes for the preparation of the quinazoline derivative. The quinazoline derivatives of formula (I), are useful in the treatment of hyperproliferative disorders such as a cancer.
